Impactiviti Daily 110209 posted on November 2, 2009TODAY’S NEWS Takeda buys into Amylin's weight-loss drug portfolio - Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase …Continue Reading about Impactiviti Daily 110209 →